湖南方盛制药股份有限公司关于2025年特别分红的公告

Core Viewpoint - The company, Hunan Fangsheng Pharmaceutical Co., Ltd., announced a special dividend for 2025, reflecting its commitment to sharing development results with investors while ensuring sustainable growth [2][3]. Dividend Distribution - The company plans to distribute a cash dividend of 0.15 yuan per share (including tax) based on the total share capital registered on the dividend distribution date [2][3]. - The total cash dividend to be distributed amounts to 65,862,204 yuan, which represents 24.55% of the net profit attributable to shareholders for the first three quarters of 2025, totaling 268,283,287.89 yuan [3]. Business Performance - Since implementing its development strategy focused on becoming an innovative traditional Chinese medicine health industry group in 2021, the company has optimized resource allocation and management, leading to steady business growth [2]. - The company has successfully developed and commercialized three innovative traditional Chinese medicine products, including Xiaoer Jingxing Cough Granules, Xuanqi Jianguo Tablets, and Yangxue Qufeng Zhitong Granules [2]. Decision-Making Process - The company received authorization from the shareholders' meeting held on May 20, 2025, to formulate and implement the 2025 mid-term cash dividend plan [6]. - The board of directors approved the special dividend plan during a meeting on January 4, 2026, with unanimous support [7].